From the only company selling nutraceutical products containing the neuroprotective dietary ingredient G-Agmatine (R) , Gilad&Gilad is excited to announce the launch of AgmaVet (R) For Horses, a new ...

As monkey prices peaked in 2022, Joinn spent about 1.8 billion yuan to acquire two laboratory monkey companies and built its ...

Ammonia is extremely useful to us as a crucial ingredient in fertilizers. But producing it also has a significant carbon ...

The agreement includes an upfront payment, with potential future payments linked to development, regulatory, and commercial milestones.

AstraZeneca is already deeply embedded in China's pharma sector, and is hungry for more, pledging $15 billion to an investment programme in the country and signing a mammoth licensing deal with Hong ...

Key market opportunities for the global small molecule healthcare contract manufacturing sector include increased demand for ...

Sequence-Based AI for Rapid Evaluation of Small Molecules and Antibodies” SAN FRANCISCO , CA, UNITED STATES, January 14, 2026 /EINPresswire.com/ — Ainnocence today announced a major milestone in ...

A living evidence approach treats evidence as shared infrastructure rather than as a series of isolated projects.

AstraZeneca has returned to CSPC with a licensing deal for the Chinese company’s monthly injectables for obesity.

Explore the potential of cardiometabolic drugs with Insilico Medicine and Qilu Pharmaceutical in developing innovative ...

The asset will be housed within Formation's newly formed subsidiary Kenmare Bio, with plans to enter the clinic in 2026.

The drugmaker's full-year results didn't seem to move the needle for investors who are instead focused on future growth ...